Watch for Bacterial, Fungal Infections in COVID Patients in the ICU
(MedPage Today) -- In a small series from Ireland, patients in the intensive care unit (ICU) for severe COVID-19 were more likely to develop serious bacterial and fungal infections when they received the IL-6 inhibitor tocilizumab (Actemra), potentially...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Actemra | COVID-19 | Fungal Infections | Infectious Diseases | Intensive Care | Ireland Health